Cargando…

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review

Background and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related dementias have limited access to effective and individualized treatment. Care p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Efthalia, Papachristou, Nikolaos, Bougea, Anastasia, Stanitsa, Evangelia, Kontaxopoulou, Dionysia, Fragkiadaki, Stella, Pavlou, Dimosthenis, Koros, Christos, Değirmenci, Yıldız, Papatriantafyllou, John, Thireos, Eleftherios, Politis, Antonios, Tsouros, Agis, Bamidis, Panagiotis, Stefanis, Leonidas, Papageorgiou, Sokratis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783876/ https://www.ncbi.nlm.nih.gov/pubmed/36556907 http://dx.doi.org/10.3390/medicina58121705

Ejemplares similares

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

How Well Did the Healthcare System Respond to the Healthcare Needs of Older People with and without Dementia during the COVID-19 Pandemic? The Perception of Healthcare Providers and Older People from the SI4CARE Project in the ADRION Region
por: Fragkiadaki, Stella, et al.
Publicado: (2023)

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report
por: Koros, Christos, et al.
Publicado: (2023)

Prosopagnosia, Other Specific Cognitive Deficits, and Behavioral Symptoms: Comparison between Right Temporal and Behavioral Variant of Frontotemporal Dementia
por: Koros, Christos, et al.
Publicado: (2022)

APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
por: Papastefanopoulou, Vasiliki, et al.
Publicado: (2022)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review
por: Bougea, Anastasia, et al.
Publicado: (2023)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review
por: Koros, Christos, et al.
Publicado: (2023)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It?
por: Kapsomenakis, Alexandros, et al.
Publicado: (2023)

The coronavirus pandemic should strengthen governments’ will to invest in adolescent health
por: Tsouros, Agis
Publicado: (2020)

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
por: Ravanidis, Stylianos, et al.
Publicado: (2020)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)

Imaging Markers for Normal Pressure Hydrocephalus: An Overview
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2023)

Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2022)

‘Social, innovative and smart cities are happy and resilient’: insights from the WHO EURO 2014 International Healthy Cities Conference
por: Kamel Boulos, Maged N, et al.
Publicado: (2015)

Silent Pauses and Speech Indices as Biomarkers for Primary Progressive Aphasia
por: Potagas, Constantin, et al.
Publicado: (2022)

Is Capacity Building Training Effective for Changing Attitudes toward Health Inequalities? Experience from a Norway Grants Project in Lithuania
por: Stankūnas, Mindaugas, et al.
Publicado: (2019)

In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
por: Ouzounoglou, Eleftherios, et al.
Publicado: (2014)

Translation, cultural adaptation and pilot testing of a questionnaire measuring the factors affecting the acceptance of telemedicine by Greek cancer patients
por: Papachristou, Nikolaos, et al.
Publicado: (2023)

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease
por: Ravanidis, Stylianos, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

Physical Training In-Game Metrics for Cognitive Assessment: Evidence from Extended Trials with the Fitforall Exergaming Platform
por: Konstantinidis, Evdokimos I., et al.
Publicado: (2021)

The Effects of a Single Session of a Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients: A Methodological Approach
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2023)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

The Assessment of the Socioemotional Disorder in Neurodegenerative Diseases with the Revised Self-Monitoring Scale (RSMS)
por: Dimitriou, Tatiana, et al.
Publicado: (2022)

Reengineering NHS Hospitals in Greece: Redistribution Leads to Rational Mergers
por: Nikolentzos, Athanasios, et al.
Publicado: (2015)

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center
por: Skarlis, Charalampos, et al.
Publicado: (2022)

Loss of β-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells
por: Dermentzaki, Georgia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mkcl84cil2d41k4uf7q8gm12to